FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2962332016> ?p ?o ?g. }

• W2962332016 endingPage "575" @default.
• W2962332016 startingPage "568" @default.
• W2962332016 abstract "Background: Meconium aspiration syndrome (MAS) is a major cause of severe respiratory failure in near- and full-term neonates. Alleviating inflammation is key to successfully treating severe MAS. Phosphodiesterase (PDE) inhibitors are known to play a role in airway smooth muscle relaxation and alveolar inflammation inhibition. This study aimed to investigate the effects of various intravenous (IV) PDE inhibitors and corticosteroids on MAS. Methods: MAS was induced in newborn piglets by instilling human meconium in them. The piglets were randomly divided into five groups (n = 5 in each group): (1) control (sham treatment); (2) dexamethasone (Dex) (IV 0.6 mg/kg of dexamethasone); (3) aminophylline (Ami) (IV 6 mg/kg of aminophylline, followed by continuous infusion of 0.5 mg/kg/h of aminophylline; (4) milrinone (Mil) (IV 50 μg/kg of milrinone, followed by continuous infusion of 0.75 μg/kg/h of milrinone); and (5) rolipram (Rol) (IV 0.8 mg/kg of rolipram). The duration of the experimental period was 4 hours. Results: Compared to the control group, all the four treatment groups revealed better oxygenation 3 hours and more after the start of treatment. The Rol group had a significantly elevated heart beat (p < 0.05) and relatively lower blood pressure compared to the other groups during the first 2 hours of the experiment. The Dex group had significantly lower interleukin (IL)-1β levels in the lung tissue compared to the other groups (p < 0.05) and significantly lower IL-6 levels compared to the Ami and Mil groups (p < 0.05). Lung histology showed slightly less inflammation and atelectasis in the Dex group compared to the other groups, but lung injury scores showed no significant between-group differences. Conclusion: Using IV corticosteroids or any type of PDE inhibitors has some beneficial effects in improving oxygenation in MAS. PDE inhibitors are not superior to IV corticosteroids; in fact, adverse cardiovascular effects occur with the phosphodiesterase type 4 (PDE4) inhibitor. Further investigations are required before using IV corticosteroids and PDE inhibitors in future clinical application." @default.
• W2962332016 created "2019-07-23" @default.
• W2962332016 creator A5020194366 @default.
• W2962332016 creator A5021055280 @default.
• W2962332016 creator A5073536677 @default.
• W2962332016 creator A5091443977 @default.
• W2962332016 date "2019-07-01" @default.
• W2962332016 modified "2023-09-23" @default.
• W2962332016 title "Effects of intravenous phosphodiesterase inhibitors and corticosteroids on severe meconium aspiration syndrome" @default.
• W2962332016 cites W173558188 @default.
• W2962332016 cites W1964583544 @default.
• W2962332016 cites W1964897436 @default.
• W2962332016 cites W1979646418 @default.
• W2962332016 cites W1982472802 @default.
• W2962332016 cites W1995135796 @default.
• W2962332016 cites W2000232773 @default.
• W2962332016 cites W2008056794 @default.
• W2962332016 cites W2009695617 @default.
• W2962332016 cites W2009934381 @default.
• W2962332016 cites W2015729233 @default.
• W2962332016 cites W2021310660 @default.
• W2962332016 cites W2025838850 @default.
• W2962332016 cites W2034651595 @default.
• W2962332016 cites W2036616331 @default.
• W2962332016 cites W2037162182 @default.
• W2962332016 cites W2049610222 @default.
• W2962332016 cites W2049682114 @default.
• W2962332016 cites W2054896413 @default.
• W2962332016 cites W2058006916 @default.
• W2962332016 cites W2061903286 @default.
• W2962332016 cites W2065166361 @default.
• W2962332016 cites W2071855864 @default.
• W2962332016 cites W2077523475 @default.
• W2962332016 cites W2078592389 @default.
• W2962332016 cites W2080446462 @default.
• W2962332016 cites W2080805449 @default.
• W2962332016 cites W2087968375 @default.
• W2962332016 cites W2092744574 @default.
• W2962332016 cites W2095239440 @default.
• W2962332016 cites W2095583096 @default.
• W2962332016 cites W2101175089 @default.
• W2962332016 cites W2103087658 @default.
• W2962332016 cites W2109143421 @default.
• W2962332016 cites W2115960040 @default.
• W2962332016 cites W2132568062 @default.
• W2962332016 cites W2135201623 @default.
• W2962332016 cites W2144716012 @default.
• W2962332016 cites W2169750357 @default.
• W2962332016 cites W2170729464 @default.
• W2962332016 cites W2343058485 @default.
• W2962332016 cites W2793513555 @default.
• W2962332016 cites W63167694 @default.
• W2962332016 doi "https://doi.org/10.1097/jcma.0000000000000063" @default.
• W2962332016 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31274789" @default.
• W2962332016 hasPublicationYear "2019" @default.
• W2962332016 type Work @default.
• W2962332016 sameAs 2962332016 @default.
• W2962332016 citedByCount "5" @default.
• W2962332016 countsByYear W29623320162020 @default.
• W2962332016 countsByYear W29623320162021 @default.
• W2962332016 countsByYear W29623320162023 @default.
• W2962332016 crossrefType "journal-article" @default.
• W2962332016 hasAuthorship W2962332016A5020194366 @default.
• W2962332016 hasAuthorship W2962332016A5021055280 @default.
• W2962332016 hasAuthorship W2962332016A5073536677 @default.
• W2962332016 hasAuthorship W2962332016A5091443977 @default.
• W2962332016 hasBestOaLocation W29623320161 @default.
• W2962332016 hasConcept C126322002 @default.
• W2962332016 hasConcept C172680121 @default.
• W2962332016 hasConcept C178853913 @default.
• W2962332016 hasConcept C181199279 @default.
• W2962332016 hasConcept C185592680 @default.
• W2962332016 hasConcept C2776136866 @default.
• W2962332016 hasConcept C2776202631 @default.
• W2962332016 hasConcept C2776645727 @default.
• W2962332016 hasConcept C2776766087 @default.
• W2962332016 hasConcept C2776954882 @default.
• W2962332016 hasConcept C2776958096 @default.
• W2962332016 hasConcept C2778095195 @default.
• W2962332016 hasConcept C2779234561 @default.
• W2962332016 hasConcept C2780401358 @default.
• W2962332016 hasConcept C2780745319 @default.
• W2962332016 hasConcept C2780985857 @default.
• W2962332016 hasConcept C42219234 @default.
• W2962332016 hasConcept C54355233 @default.
• W2962332016 hasConcept C55493867 @default.
• W2962332016 hasConcept C62826618 @default.
• W2962332016 hasConcept C71924100 @default.
• W2962332016 hasConcept C86803240 @default.
• W2962332016 hasConcept C90924648 @default.
• W2962332016 hasConceptScore W2962332016C126322002 @default.
• W2962332016 hasConceptScore W2962332016C172680121 @default.
• W2962332016 hasConceptScore W2962332016C178853913 @default.
• W2962332016 hasConceptScore W2962332016C181199279 @default.
• W2962332016 hasConceptScore W2962332016C185592680 @default.
• W2962332016 hasConceptScore W2962332016C2776136866 @default.
• W2962332016 hasConceptScore W2962332016C2776202631 @default.
• W2962332016 hasConceptScore W2962332016C2776645727 @default.

• next